Serine protease inhibitors (serpins): Where mechanism meets medicine

Nature Medicine

Volumn 2, Issue 6, 1996, Pages 632-633

  Rubin, Harvey ^a  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

SERINE PROTEINASE; SERINE PROTEINASE INHIBITOR;

CANCER; ENZYME ACTIVITY; ENZYME INHIBITION; FIBRINOLYSIS; INFLAMMATION; NOTE; PRIORITY JOURNAL; THROMBOSIS;

ALPHA 1-ANTITRYPSIN DEFICIENCY; AMINO ACID SEQUENCE; ANIMALS; APOPTOSIS; EMPHYSEMA; FIBROSIS; HUMANS; MICE; MICE, TRANSGENIC; MODELS, BIOLOGICAL; MODELS, MOLECULAR; MOLECULAR SEQUENCE DATA; PLASMINOGEN ACTIVATOR INHIBITOR 1; PROTEIN CONFORMATION; SERINE PROTEINASE INHIBITORS;

EID: 0029941477     PISSN: 10788956     EISSN: None     Source Type: Journal    
DOI: 10.1038/nm0696-632     Document Type: Note

References (14)

1. Travis, J. & Salvesen, G.S. Human plasma proteinase inhibitors. Ann. Rev. Biochem. 52, 655-709 (1983).
2. Eitzman, D.T. et al. Bleomycin-induced pulmonary fibrosis in transgenic mice that either lack or overexpress the murine plasminogen activator inhibitor-1 gene. J. Clin. Invest. 97, 232-237 (1996).
3. Romer, J. et al. Impaired wound healing in mice with a disrupted plasminogen gene. Nature Med. 2, 287-292 (1996).
4. Kopf, M. et al. Impaired immune and acute phase responses in interleukin-6-deficient mice. Nature 369, 339-342 (1994)
5. Tanaka, M. et al. Fas ligand in human serum. Nature Med. 2, 317-322 (1996).
6. Enari, M., Talanian, R.V., Wong, W.W. & Nagata, S. Sequential activation of ICE-like and CPP32-like proteases during Fas-mediated apoptosis. Nature 380, 723-726 (1996).
7. Kumar, S. & Harvey, N.L. Role of multiple cellular proteases in the execution of programmed cell death. FEBS Lett. 375, 169-173 (1995)
8. Mignatti, P. & Rifkin, D.B. Biology and biochemistry of proteinases in tumor invasion. Physiol. Rev. 73, 161-195 (1993)
9. Wei, A., Rubin, H., Cooperman, B.S. & Christianson, D.W. Crystal structure of an uncleaved serpin reveals the conformation of an inhibitory reactive loop. Nature Struct. Biol. 1, 251-258 (1994).
10. Schreuder, H.A. et al. The intact and cleaved human antithrombin III complex as a model for serpin-protease interactions. Nature Struct. Biol. 1, 48-54 (1994).
11. Carrell, R.W., Stein, P.E., Fermi, G. & Wardell, M.R. Biological implications of a 3A structure of dimeric antithrombin. Nature Struct. Biol. 2, 257-270 (1994).
12. Lawrence, D.A. et al. Serpin-protease complexes are trapped as stable acyl-enzyme intermediates. J. Biol. Chem. 270, 25309-25312 (1995).
13. Wilczynska, M., Fa, M., Ohlsson, P-I. & Ny, T. The inhibition mechanism of serpins: evidence that the mobile reactive center loop is cleaved in the native protease-inhibitor complex. J. Biol. Chem. 270, 29652-29655 (1995).
14. Plotnick, M.I., Mayne, L., Schechter, N.M. & Rubin, H. Distortion of the active site of chymotrypsin complexed with a serpin. Biochemistry (in the press).